SCHEMBL7979950

SCHEMBL7979950

Cc1cccc(Cl)c1Nc1nc2cc(Cl)ccc2n2cnc(P(=O)(O)O)c12

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7980350 0.95 LCK (0.45) LCK
SCHEMBL7979667 0.89 LCK (0.59) LCK
SCHEMBL7982142 0.87 LCK (0.41) LCK
SCHEMBL7969544 0.83 LCK (0.40) LCK
SCHEMBL7979769 0.82 LCK (0.39) LCK
SCHEMBL7980178 0.82 LCK (0.55) LCK
SCHEMBL7980759 0.80 LCK (0.41) LCK
SCHEMBL7983562 0.77 LCK (0.39) LCK
SCHEMBL7979942 0.76 LCK (0.56) LCK
SCHEMBL7979874 0.76 LCK (0.80) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed